Australia’s economy just took a sharp hit. More than $8 billion was wiped off the stock market in a single day. Investors sold shares at speed, fearing global and local risks. This fall is not just numbers on a screen. It shows how fragile our economy can be when global pressures rise. At the same…
Nintendo was recently granted a U.S. patent that formalizes a gameplay loop for summoning a secondary character that can fight on the player’s behalf. The patent, recorded as U.S. Patent No. 12,403,397, traces to an application filed in March 2023, and it arrives against the backdrop of Nintendo’s legal tensions tied to Palworld. This development…
Oracle’s AI cloud expansion propels shares to a record high, boosting Larry Ellison’s net worth. Learn about this groundbreaking development and its 3
Explore the critical SAP S/4HANA vulnerability impacting the German software giant and its market implications. Learn about the exploitation, SAP’s S/
Oracle’s AI cloud infrastructure deals push ORCL shares to new heights. Discover the impact and future prospects in this detailed analysis.
Discover how Oracle’s AI cloud expansion and contracts have led to a significant surge in Oracle stock, reaching record highs in 2025.
The Australian Government has unveiled a fresh Centrelink Plan aimed at easing the financial pressure on households. With the rising cost of living, this initiative promises relief, offering eligible families up to $1,460 in additional support. Australians hail the move as a practical measure that could help them manage their budgets more effectively while also…
We’ve just gotten some big news from Nintendo. On Friday, September 12, 2025, Nintendo will hold a new Nintendo Direct presentation, about 60 minutes of announcements for both the Switch and the incoming Switch 2. This Direct comes just a day before Mario’s 40th anniversary, which makes it a very special occasion. Mario has meant…
Discover how Fidelity’s launch of Europe’s first semi-transparent active ETF marks a new era in innovative investment options.
The pharmaceutical industry has seen another major shift as Zentiva, one of Europe’s leading generic drugmakers, is set to be acquired by private equity firm GTCR in a deal valued at $4.8 billion. This transaction highlights the rising demand for affordable medicines, strategic investments in healthcare, and the growing importance of innovative financing in the…